Cited by

• Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

  Hänsch GM, Hammer CH, Vanguri P, Shin ML. Hänsch GM, et al. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5118-21. doi: 10.1073/pnas.78.8.5118. Proc Natl Acad Sci U S A. 1981. PMID: 6946459 Free PMC article.
• Effect of agents that produce membrane disorder on lysis of erythrocytes by complement.

  Shin ML, Hänsch G, Mayer MM. Shin ML, et al. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2522-5. doi: 10.1073/pnas.78.4.2522. Proc Natl Acad Sci U S A. 1981. PMID: 6941304 Free PMC article.
• Homologous species restriction of the complement-mediated killing of nucleated cells.

  Yamamoto H, Blaas P, Nicholson-Weller A, Hänsch GM. Yamamoto H, et al. Immunology. 1990 Aug;70(4):422-6. Immunology. 1990. PMID: 1697561 Free PMC article.
• Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel.

  Ramm LE, Whitlow MB, Mayer MM. Ramm LE, et al. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4751-5. doi: 10.1073/pnas.79.15.4751. Proc Natl Acad Sci U S A. 1982. PMID: 6289316 Free PMC article.
• Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.

  Rosenfeld SI, Packman CH, Leddy JP. Rosenfeld SI, et al. J Clin Invest. 1983 Apr;71(4):795-808. doi: 10.1172/jci110833. J Clin Invest. 1983. PMID: 6403580 Free PMC article.